Medical Market Report

Global Non-opioid Pain Patches Market By Type (Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch, Other), By Application (Hospital Pharmacies, Independent Pharmacies & Drug Stores, Online Pharmacies), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135439
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Non-opioid Pain Patches Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The Global non-opioid pain patches Market is segmented on the basis of Type, Application, and geography.
    The Worldwide market for Global Non-opioid Pain Patches Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Non-opioid Pain Patches Market Scope:

    By type, the market is segmented into Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch, and Other. By Application, the market is divided into Hospital Pharmacies, Independent Pharmacies & Drug Stores, and Online Pharmacies.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical, Teikoku Seiyaku, IBSA Institut Biochimque SA, Acorda Therapeutics, Allergan PLC, and Endo International.

    Key Market Segments

    Type

    Lidocaine Patch
    Diclofenac Patch
    Methyl Salicylate Patch
    Capsaicin Patch
    Ketoprofen Patch
    Other

    Application

    Hospital Pharmacies
    Independent Pharmacies & Drug Stores
    Online Pharmacies

    Key Market Players included in the report:

    Pfizer
    GlaxoSmithKline
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Hisamitsu Pharmaceutical
    TEH SENG Pharmaceutical
    Teikoku Seiyaku
    IBSA Institut Biochimque SA
    Acorda Therapeutics
    Allergan PLC
    Endo International

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Non-opioid Pain Patches Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Non-opioid Pain Patches Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Non-opioid Pain Patches Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the Global Non-opioid Pain Patches Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Non-opioid Pain Patches Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Non-opioid Pain Patches Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Non-opioid Pain Patches Market sub-markets, depending on key regions (various vital states).
    To analyze Global Non-opioid Pain Patches Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Non-opioid Pain Patches Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Non-opioid Pain Patches Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Non-opioid Pain Patches Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Non-opioid Pain Patches Market Overview
    

    3.1. Global Non-opioid Pain Patches Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Non-opioid Pain Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Non-opioid Pain Patches Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Lidocaine Patch
    
4.4. Diclofenac Patch
    
4.5. Methyl Salicylate Patch
    
4.6. Capsaicin Patch
    
4.7. Ketoprofen Patch
    
4.8. Other5. Global Non-opioid Pain Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Non-opioid Pain Patches Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Hospital Pharmacies
    
5.4. Independent Pharmacies & Drug Stores
    
5.5. Online Pharmacies6. Global Non-opioid Pain Patches Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Global Non-opioid Pain Patches Market: Regional Trend Analysis
    

    6.1.1. 1.US
    
6.1.1. 2.Canada
    
6.1.1. 3.Mexico
    

    6.2. Europe
    

    6.2.1. Europe Global Non-opioid Pain Patches Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Global Non-opioid Pain Patches Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4.India
    
6.3.1.5.Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Global Non-opioid Pain Patches Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Global Non-opioid Pain Patches Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Non-opioid Pain Patches Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Pfizer
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. GlaxoSmithKline
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Johnson & Johnson
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Novartis AG
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Mylan N.V.
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Teva Pharmaceutical Industries
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Hisamitsu Pharmaceutical
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. TEH SENG Pharmaceutical
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Teikoku Seiyaku
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. IBSA Institut Biochimque SA
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Acorda Therapeutics
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Allergan PLC
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. Endo International
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.